Ahn-Gook Pharmaceutical Co. Ltd (001540) - Total Liabilities
Based on the latest financial reports, Ahn-Gook Pharmaceutical Co. Ltd (001540) has total liabilities worth ₩136.13 Billion KRW (≈ $92.25 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 001540 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Ahn-Gook Pharmaceutical Co. Ltd - Total Liabilities Trend (2011–2024)
This chart illustrates how Ahn-Gook Pharmaceutical Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 001540 asset base.
Ahn-Gook Pharmaceutical Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Ahn-Gook Pharmaceutical Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Welltend Technology Corp
TW:3021
|
Taiwan | NT$1.59 Billion |
|
Saunders International Ltd
AU:SND
|
Australia | AU$50.47 Million |
|
Abionyx Pharma SA
PA:ABNX
|
France | €7.56 Million |
|
Single Well Industrial
TWO:3490
|
Taiwan | NT$788.67 Million |
|
Associated Capital Group Inc
NYSE:AC
|
USA | $38.70 Million |
|
Mediaco Holding Inc
NASDAQ:MDIA
|
USA | $239.05 Million |
|
NICE Total Cash Management Co. Ltd
KQ:063570
|
Korea | ₩471.11 Billion |
|
Blink Charging Co
NASDAQ:BLNK
|
USA | $82.96 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down Ahn-Gook Pharmaceutical Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Ahn-Gook Pharmaceutical Co. Ltd's balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.79 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.81 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ahn-Gook Pharmaceutical Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ahn-Gook Pharmaceutical Co. Ltd (2011–2024)
The table below shows the annual total liabilities of Ahn-Gook Pharmaceutical Co. Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩136.86 Billion ≈ $92.75 Million |
+57.43% |
| 2023-12-31 | ₩86.93 Billion ≈ $58.91 Million |
+25.78% |
| 2022-12-31 | ₩69.11 Billion ≈ $46.84 Million |
+3.88% |
| 2021-12-31 | ₩66.54 Billion ≈ $45.09 Million |
+15.51% |
| 2020-12-31 | ₩57.60 Billion ≈ $39.04 Million |
-17.37% |
| 2019-12-31 | ₩69.71 Billion ≈ $47.24 Million |
+5.37% |
| 2018-12-31 | ₩66.16 Billion ≈ $44.83 Million |
-6.96% |
| 2017-12-31 | ₩71.11 Billion ≈ $48.19 Million |
+8.77% |
| 2016-12-31 | ₩65.37 Billion ≈ $44.30 Million |
-2.12% |
| 2015-12-31 | ₩66.79 Billion ≈ $45.26 Million |
+18.00% |
| 2014-12-31 | ₩56.61 Billion ≈ $38.36 Million |
+53.74% |
| 2013-12-31 | ₩36.82 Billion ≈ $24.95 Million |
-31.14% |
| 2012-12-31 | ₩53.47 Billion ≈ $36.24 Million |
+3.29% |
| 2011-12-31 | ₩51.77 Billion ≈ $35.08 Million |
-- |
About Ahn-Gook Pharmaceutical Co. Ltd
Ahn-Gook Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products. The company's pharmaceutical products include Cinatura and Revo Tension. The company was founded in 1959 and is headquartered in Seoul, South Korea.